206 research outputs found
ΠΠΠΠΠΠΠΠ ΠΠ»Π°Π΄ΠΈΠΌΠΈΡ ΠΠΎΡΠΈΡΠΎΠ²ΠΈΡ (ΠΊ 75-Π»Π΅ΡΠΈΡ ΡΠΎ Π΄Π½Ρ ΡΠΎΠΆΠ΄Π΅Π½ΠΈΡ)
SERUM LEVELS OF HEMOPOIETIC AND ANGIOGENESIS GROWTH FACTORS (IL-5, IL-7, IL-9, FGF-Ξ², G-CSF, VEGF AND PDGF) IN WOMEN WITH UTERINE MYOMA
Uterine leiomyomas are common benign tumors developing from smooth muscle tissues, often leading to infertility and recurrent abortions. Pregnancy and development of uterine fibroids are characterized by an unusual rate of myometrium growth, hyperproduction of extracellular matrix and increased expression of numerous growth factor receptors. The purpose of this study was to determine concentrations of some key growth factors (IL-5, IL-7, IL-9, FGF-Ξ², G-CSF, VEGF and PDGF) in blood serum of women with uterine myoma. Concentrations of the 27 cytokines were determined using a Bio Rad kit (USA) β Bio-Plex Proβ’. Human Cytokine 27-plex Assay by means of flow-through fluorometry at the Bio-Plex 200 double-beam laser analyzer. Thirty-six patients with verified uterine myoma were followed up, being later subject to operative treatment (laparoscopic myomectomy). The results of this study showed a trend to decreased amounts of some hematopoiesis and angiogenesis growth factors, e.g., IL-9 and FGF, in blood serum of women with uterine myoma. Π‘oncentrations of IL-5, IL-7, and G-CSF proved to be significantly decreased if compared to serum contents of European healthy women. The most significant decrease was registered for pro-angiogenic factors, such as VEGF and PDGF. Their serum concentration in women with leiomyoma was reduced, respectively, 3- and 6-fold against controls. The decreased G-CSF concentration was not only quite significant, as compared to healthy women, but showed significant correlations with changes of such factors as IL-5, IL-7 and IL-9, with correlation quotients of, resp., 0.723, 0.637, and 0.504, respectively. One may conclude that, in spite of literature data on significantly increased contents of the mentioned growth factors in tissues of myometrium and growing uterine leiomyoma, our data show that the concentrations of these regulatory proteins in blood serum are decreased to some extent in this clinical condition
ΠΠΠΠΠΠΠΠ ΠΠΠ‘ΠΠ€ΠΠΠΠ§ ΠΠΠΠΠΠΠΠ
.12 ΠΈΡΠ»Ρ ΠΈΡΠΏΠΎΠ»Π½ΠΈΠ»ΠΎΡΡ 70 Π»Π΅Ρ Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΊΡ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΠΈ Π½Π°ΡΠΊ, Π·Π°ΡΠ»ΡΠΆΠ΅Π½Π½ΠΎΠΌΡ Π΄Π΅ΡΡΠ΅Π»Ρ Π½Π°ΡΠΊΠΈ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ, Π½Π°ΡΡΠ½ΠΎΠΌΡ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΠΈΡΠ΅Π»Ρ ΠΠ°ΡΡΠ½ΠΎ-ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΎΠ³ΠΎ ΠΈΠ½ΡΡΠΈΡΡΡΠ° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ Π»ΠΈΠΌΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΎΡΡ ΠΠ»Π°Π΄ΠΈΠΌΠΈΡΡ ΠΠΎΡΠΈΡΠΎΠ²ΠΈΡΡ ΠΠΎΠ½Π΅Π½ΠΊΠΎΠ²Ρ
Special aspects of the national, cultural and charitable activities of Ukrainian entrepreneurs in the second half of the XIX-th β the early XX-th century
ΠΠ½Π°Π»ΡΠ·ΡΡΡΡΡΡ ΠΎΡΠΎΠ±Π»ΠΈΠ²ΠΎΡΡΡ Π²ΠΏΠ»ΠΈΠ²Ρ Π² ΠΏΠΎΡΠ΅ΡΠΎΡΠΌΠ΅Π½ΠΈΠΉ ΠΏΠ΅ΡΡΠΎΠ΄ Π½Π° Π½Π°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΊΡΠ»ΡΡΡΡΠ½ΠΈΠΉ ΡΠΎΠ·Π²ΠΈΡΠΎΠΊ ΠΠ°Π΄Π΄Π½ΡΠΏΡΡΠ½ΡΡΠΊΠΎΡ Π£ΠΊΡΠ°ΡΠ½ΠΈ Π½Π°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎΡ Π±ΡΡΠΆΡΠ°Π·ΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠΌΠΎΠ²ΠΈ ΡΠΎΡΠΌΡΠ²Π°Π½Π½Ρ ΡΠΊΡΠ°ΡΠ½ΡΡΠΊΠΎΡ Π±ΡΡΠΆΡΠ°Π·ΡΡ ΡΠ° ΡΠΏΠ΅ΡΠΈΡΡΠΊΡ ΡΡ Π΄ΡΡΠ»ΡΠ½ΠΎΡΡΡ Π² Π ΠΎΡΡΠΉΡΡΠΊΡΠΉ ΡΠΌΠΏΠ΅ΡΡΡ Π·Π° ΠΏΠ΅Π²Π½ΠΈΡ
ΠΎΠ±ΡΡΠ°Π²ΠΈΠ½ ΠΏΠΎΠ»ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΡΠΊΡΠ°ΡΠ½ΡΡΠΊΠΎΠ³ΠΎ ΡΡΡΠΏΡΠ»ΡΡΡΠ²Π°. ΠΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½ΠΎ ΠΊΠΎΠ½ΠΊΡΠ΅ΡΠ½Ρ ΠΏΡΠΈΠΊΠ»Π°Π΄ΠΈ Π½Π°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΡ Π΄ΡΡΠ»ΡΠ½ΠΎΡΡΡ ΡΠΊΡΠ°ΡΠ½ΡΡΠΊΠΈΡ
ΠΏΡΠ΄ΠΏΡΠΈΡΠΌΡΡΠ², Π° ΡΠ°ΠΌΠ΅: ΠΌΠ΅ΡΠ΅Π½Π°ΡΡΡΠ²Π° ΡΠ° Π΄ΠΎΠ±ΡΠΎΡΠΈΠ½Π½ΠΎΡΡΡ, ΡΠΎ Π½Π΅ Π»ΠΈΡΠ΅ ΡΠΏΡΠΈΡΠ»ΠΈ ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠΌΡ ΡΠΎΠ·Π²ΠΈΡΠΊΡ ΡΡΠ΄Π½ΠΎΠ³ΠΎ ΠΊΡΠ°Ρ, Π° ΠΉ Π·Π°ΡΠΎΠ΄ΠΆΠ΅Π½Π½Ρ ΡΠΊΡΠ°ΡΠ½ΡΡΠΊΠΎΡ ΠΌΠΎΠ΄Π΅ΡΠ½ΠΎΡ Π½Π°ΡΡΡ.The article deals with the influence of the national bourgeoisie on the national cultural development of Nadnipryanska Ukraine in the second half of the XX-th century (post-reform period). The backgrounds of forming and tendencies of realization of charitable activity of Ukrainian entrepreneurs are presented in the work. Among them β insufficient quantity of Ukrainian economic elite (contrary to prevailing of foreign ones), where there were only several prominent families β Symyrenky, Tereshchenky, Kharytonenky, Alchevski, Chekalenky; dependence of the Ukrainian entrepreneurs from the central authorities which stipulated the restrained support by them the national interests. Besides that, a separation between different Ukrainian strata did not always contribute to the consolidation of society. However Ukrainian reality revealed specific examples of the national charitable activities of Ukrainian bourgeoisie dealing with the health protection, arts and educational spheres. Charity of Ukrainian entrepreneurs not only favoured the cultural level of their native land, but led to the origin and development of a modern Ukrainian nation.ΠΠ½Π°Π»ΠΈΠ·ΠΈΡΡΡΡΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π²Π»ΠΈΡΠ½ΠΈΡ Π² ΠΏΠΎΡΠ΅ΡΠΎΡΠΌΠ΅Π½Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π½Π° Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΠΠ°Π΄Π΄Π½Π΅ΠΏΡΡΠ½ΡΠΊΠΎΠΉ Π£ΠΊΡΠ°ΠΈΠ½Ρ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π±ΡΡΠΆΡΠ°Π·ΠΈΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½Ρ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠ»ΠΊΠΈ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΊΡΠ°ΠΈΠ½ΡΠΊΠΎΠΉ Π±ΡΡΠΆΡΠ°Π·ΠΈΠΈ ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΠΊΠ° Π΅Π΅ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΏΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΊΡΠ°ΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ΅ΡΡΠ²Π°. ΠΡΡΠ»Π΅Π΄ΡΡΡΡΡ ΠΊΠΎΠ½ΠΊΡΠ΅ΡΠ½ΡΠ΅ ΠΏΡΠΈΠΌΠ΅ΡΡ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠΉ Π±Π»Π°Π³ΠΎΡΠ²ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ ΠΌΠ΅ΡΠ΅Π½Π°ΡΡΡΠ²Π° ΠΈ Π±Π»Π°Π³ΠΎΡΠ²ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΡΠΊΡΠ°ΠΈΠ½ΡΠΊΠΈΡ
ΠΏΡΠ΅Π΄ΠΏΡΠΈΠ½ΠΈΠΌΠ°ΡΠ΅Π»Π΅ΠΉ, ΡΡΠΎ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°Π»ΠΎ Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ ΠΊΡΠ»ΡΡΡΡΠ½ΠΎΠΌΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΊΡΠ°Ρ, Π½ΠΎ ΠΈ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΊΡΠ°ΠΈΠ½ΡΠΊΠΎΠΉ ΠΌΠΎΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π°ΡΠΈΠΈ
ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 2, 3, 9 ΠΈ ΡΠΊΠ°Π½Π΅Π²ΡΡ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 1, 2, 3, 4 Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΠΎΠΉ
Aim. To study the content of matrix metalloproteinase (MMP)-2, -3, -9 and tissue inhibitors of metalloproteinases (TIMPs) -1, -2, -3, -4 in the aqueous humor of patients with moderate primary open-angle glaucoma (POAG).Materials and methods. The experimental group included 47 patients with verified moderate primary open-angle glaucoma. The control group consisted of 26 patients with uncomplicated cataract. The levels of MMP-2, -3, -9 were determined with Luminex Performance Human MMP Magnetic Panel 3-plex kit (R&D Systems, USA), the concentration of TIMPs-1, -2, -3, - 4 was determined with the Human TIMP Magnetic Luminex Performance Assay 4-plex kit (R&D Systems, USA). The study was carried out using flow-through field fluorometry on a Bio-Plex 200 double-beam laser analyzer (Bio-Rad, USA).Results. The study showed a statistically significant increase in the levels of matrix metalloproteinase-2 and tissue inhibitors of matrix metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with moderate POAG compared with patients with uncomplicated cataract.Conclusion. The obtained data on high concentrations and imbalance in the levels of matrix metalloproteinases and their tissue inhibitors in the aqueous humor of patients with moderate POAG confirm the role of local inflammation, as well as impairments in the structure of the extracellular matrix and its remodeling in the mechanisms of development of this pathology.Β Π¦Π΅Π»Ρ β ΠΈΠ·ΡΡΠΈΡΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· (ΠMP) 2, 3, 9 ΠΈ ΡΠΊΠ°Π½Π΅Π²ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· (TIMP) 1, 2, 3, 4 Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 47 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π²Π΅ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ, Π½Π° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΡΡΠ°Π»ΡΠΌΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ, Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ. ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 26 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ Β«Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½Π°Ρ ΠΊΠ°ΡΠ°ΡΠ°ΠΊΡΠ°Β». ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ MMP-2, MMP-3, MMP-9 ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π½Π°Π±ΠΎΡΠ° Luminex Performance Human MMP Magnetic Panel (3-Plex) (R&D Systems, Π‘Π¨Π), ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ TIMP-1, TIMP-2, TIMP-3, TIMP-4 ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π½Π°Π±ΠΎΡΠ° Human TIMP Magnetic Luminex Performance Assay 4-plex (R&D Systems, Π‘Π¨Π). ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠ»ΡΠΎΡΠΈΠΌΠ΅ΡΡΠΈΠΈ Π½Π° Π΄Π²ΡΡ
Π»ΡΡΠ΅Π²ΠΎΠΌ Π»Π°Π·Π΅ΡΠ½ΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ Bio-Plex 200 (Bio-Rad, Π‘Π¨Π).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π²ΡΡΠΎΠΊΠ°Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΠΎΠΉ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Ρ-2 ΠΈ ΡΠΊΠ°Π½Π΅Π²ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· 1, 2, 3, 4 Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π΄Π°Π½Π½ΡΡ
, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ Π»ΠΈΡ Ρ Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠΉ ΠΊΠ°ΡΠ°ΡΠ°ΠΊΡΠΎΠΉ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π²ΡΡΠΎΠΊΠΈΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡΡ
ΠΈ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΈ Π±Π°Π»Π°Π½ΡΠ° ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΌΠ°ΡΡΠΈΠΊΡΠ½ΡΡ
ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π· ΠΈ ΠΈΡ
ΡΠΊΠ°Π½Π΅Π²ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² Π² Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡ ΡΠΎΠ»Ρ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΡΡΡΠΊΡΡΡΡ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊΡΠ° ΠΈ Π΅Π³ΠΎ ΡΠ΅ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π² ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°Ρ
ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°.
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΠΎΠΉ
Purpose. To study the content of cytokines and growth factors in the intraocular fluid of patients with developed stage of primary open-angle glaucoma (POAG).Materials and methods. 56 patients with a verified diagnosis developed stage of primary open-angle glaucomawere examined. The control group consisted of 30 patients with a diagnosis of uncomplicated cataract. A concentration of 17 cytokinesand 3 isoforms of the transforming growth factor (TGF) Ξ² was determined using a Bio-Plex Proβ’ Human Cytokine 17-plex Assay and Bio-Plex Proβ’ and TGFΞ² 3-plex Assay kit by flow-through fluorometry on a Bio-Plex 200, Bio-Rad double beam laser analyzer, USA.Results. Astatistically significant increase was shown in the concentrations of cytokines and growth factors (interleukins (IL) 4, 6, 7, 8, 12, 17, TGFΞ² 1, 2, 3, macrophage inflammatory protein 1 Ξ²) in the intraocular fluid of patients with developed stage of the primary open-angle glaucoma in respect to data obtained from the study of the intraocular fluid of the persons with uncomplicated cataract, as well as a statistically significant decrease in the concentrations IL-2, IL-10, granulocyte-macrophage colony-stimulating factor.Conclusion. In the pathogenesis of primary open-angle glaucoma, the activity of the local chronic inflammatory process is determined. This is confirmed by statistically significant changes in the studied cytokines and growth factors. Increase in the concentrations of the studied representatives of the superfamily of transforming growth factors-beta, which have anti-inflammatory activity, the ability to stimulate proliferation, cell growth, synthesis of extracellular matrix proteins, etc., attests to their importance in the mechanisms of primary open-angle glaucoma development. Increase concentrations of IL-7 in the intraocular fluid of patients with primary open-angle glaucoma allows us to assume participation in the pathogenesis of the primary open-angle glaucoma of this autocrine mediator of activation of the growth of lymphatic structures.Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠ»ΠΈ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 56 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π²Π΅ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ Π½Π° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΡΡΠ°Π»ΡΠΌΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ. ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 30 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ Β«Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½Π°Ρ ΠΊΠ°ΡΠ°ΡΠ°ΠΊΡΠ°Β». ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ 17 ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΈ ΡΡΠ΅Ρ
ΠΈΠ·ΠΎΡΠΎΡΠΌ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° ΡΠΎΡΡΠ° (Π’Π€Π ) Ξ² ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π½Π°Π±ΠΎΡΠ° Bio-Plex Proβ’ Human Cytokine 17-plex Assay ΠΈ Bio-Plex Proβ’ TGFΞ² 3-plex Assay (Bio-Rad, Π‘Π¨Π) ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠ»ΡΠΎΡΠΈΠΌΠ΅ΡΡΠΈΠΈ Π½Π° Π΄Π²ΡΡ
Π»ΡΡΠ΅Π²ΠΎΠΌ Π»Π°Π·Π΅ΡΠ½ΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π°ΡΠΎΡΠ΅ Bio-Plex 200 (Bio-Rad, Π‘Π¨Π).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΠ΅ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠΎΠΊΠΈΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Π·Π²ΠΈΡΠΎΠΉ ΡΡΠ°Π΄ΠΈΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ Π΄Π°Π½Π½ΡΡ
, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ Π»ΠΈΡ Ρ Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠΉ ΠΊΠ°ΡΠ°ΡΠ°ΠΊΡΠΎΠΉ (ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Ρ (ΠΠ) 4, 6, 7, 8, 12, 17, Π’Π€Π Ξ² 1, 2, 3, ΠΌΠ°ΠΊΡΠΎΡΠ°Π³Π°Π»ΡΠ½ΡΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠ΅ΠΈΠ½ (ΠΠΠ) 1Ξ²), Π° ΡΠ°ΠΊΠΆΠ΅ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π±ΠΎΠ»Π΅Π΅ Π½ΠΈΠ·ΠΊΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΠ-2, ΠΠ-10, Π³ΡΠ°Π½ΡΠ»ΠΎΡΠΈΡΠ°ΡΠ½ΠΎ-ΠΌΠ°ΠΊΡΠΎΡΠ°Π³Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠ΅ΡΡΠΈΠΌΡΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ°.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°. ΠΡΠΎ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°Π΅ΡΡΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΡΠΌΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΠΌΠΈ ΠΈΠ·ΡΡΠ°Π΅ΠΌΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ² ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ°. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ΅ Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ ΠΏΡΠ΅Π΄ΡΡΠ°Π²ΠΈΡΠ΅Π»Π΅ΠΉ ΡΡΠΏΠ΅ΡΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΡΡΡΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Ξ², ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΡ
ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ, ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ ΡΡΠΈΠΌΡΠ»ΠΈΡΠΎΠ²Π°ΡΡ ΠΏΡΠΎΡΠ΅ΡΡΡ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠΈ, ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°, ΡΠΈΠ½ΡΠ΅Π· Π±Π΅Π»ΠΊΠΎΠ² Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊΡΠ° ΠΈ Π΄Ρ., ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎΠ± ΠΈΡ
Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ Π² ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°Ρ
ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ. ΠΡΡΠ²Π»Π΅Π½Π½ΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π²ΠΎ Π²Π½ΡΡΡΠΈΠ³Π»Π°Π·Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ ΠΠ-7, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΡ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΡΠΊΡΡΡΠΎΡΠ³ΠΎΠ»ΡΠ½ΠΎΠΉ Π³Π»Π°ΡΠΊΠΎΠΌΡ ΡΡΠΎΠ³ΠΎ Π°ΡΡΠΎΠΊΡΠΈΠ½Π½ΠΎΠ³ΠΎ ΠΌΠ΅Π΄ΠΈΠ°ΡΠΎΡΠ° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ ΡΠΎΡΡΠ° Π»ΠΈΠΌΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΡΡΠΊΡΡΡ
ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΎΡΠ±ΡΠΈΠΎΠ½Π½ΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π² ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠΈΡΡΠ΅ΠΌ Π΄ΠΎΡΡΠ°Π²ΠΊΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ Π²Π΅ΡΠ΅ΡΡΠ²
ΠΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΎΠ±Π·ΠΎΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΠΎΡΠ±ΡΠΈΠΎΠ½Π½ΡΡ
ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π² ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠΈΡΡΠ΅ΠΌ Π΄ΠΎΡΡΠ°Π²ΠΊΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
Π²Π΅ΡΠ΅ΡΡΠ², ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° ΠΌΠΎΠ΄Π΅Π»Ρ ΡΠΎΡΠ±ΡΠΈΠΎΠ½Π½ΠΎΠΉ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ
Composition based on aluminum oxide and polydimethylsiloxane matrix for enhancing drug targeting
Methodological approaches developed at Research Institute of Clinical and Experimental Lymphology for a number of years allow formulating the importance of embedding active pharmaceutical ingredients (API) in the structure of porous carriers (sorbents). The composition of the carrier and API is an enteral system for prolonged dosing of pharmacological agents, which allows providing a specific pharmacological effect and safety of use. The pores of the media (sorbents)Β act as containers for API. This is especially important for rapidly absorbed drugs, which include, for example, lithium preparations that are used in narrow concentration limits due to their side effects. At the moment, an innovative technology for creating new medicines with an improved combination of efficiency and safety (pharmacological upgrade) has been developed and implemented. The essence of the technology is to create a composition of aluminum oxide and polydimethylsiloxane (matrix) and an active pharmacological ingredient (API). A study of two drugs based on matrix / lithium citrate and matrix / melatonin showed continued specific pharmacological activity of API, better pharmacokinetics, and better safety parameters. The matrix of aluminum oxide and polydimethylsiloxane provides an upgrade of the pharmacological properties of drugs for the dosed and safe delivery of API to the zone of their therapeutic effect
- β¦